Sun Pharmaceuticals reported 21.76B in EBIT for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Aspen Pharmacare APN:SJ 3.9B 313M
Bharat Petroleum BPCL:IN 36.16B 15.93B
Cipla CIPLA:IN 9.73B 1.12B
Dr.Reddys Laboratories DRRD:IN 10.66B 4.31B
Jiangsu Hengrui Me. 600276:CH 1.68B 320.6M
Reliance Infra RELI:IN 187.9B 23.05B
Sh Fosun Pharma 600196:CH 673.72M 178.98M
Sun Pharmaceuticals SUNP:IN 21.76B 620.6M
UPL UPLL:IN 14.79B 1.67B